반응식
[NH:1]1[C:9]2[C:4](=[CH:5][C:6]([NH:10][C:11]3[C:12]([C:18]([NH2:20])=[O:19])=[N:13][CH:14]=[C:15](Cl)[N:16]=3)=[CH:7][CH:8]=2)[CH:3]=[N:2]1.CCN(C(C)C)C(C)C.[C@@H:30]1([NH2:37])[CH2:35][CH2:34][CH2:33][CH2:32][C@@H:31]1[NH2:36].C(O)(C(F)(F)F)=O>CN1C(=O)CCC1.O>[NH:1]1[C:9]2[C:4](=[CH:5][C:6]([NH:10][C:11]3[C:12]([C:18]([NH2:20])=[O:19])=[N:13][CH:14]=[C:15]([NH:36][C@@H:31]4[CH2:32][CH2:33][CH2:34][CH2:35][C@@H:30]4[NH2:37])[N:16]=3)=[CH:7][CH:8]=2)[CH:3]=[N:2]1참가 물질
7
반응물 4
생성물 1
시약·촉매·용매 2
반응 조건
- 온도
- 150 °C
실험 절차
To 3-(1H-indazol-5-ylamino)-5-chloropyrazine-2-carboxamide (˜100 mg) in ˜3 mL NMP was added 6 equivalents of DIEA and 20 equivalents of racemic cis-1,2-cyclohexanediamine. The mixture was heated at 150° C. in a sealed tube overnight. The reaction mixture was cooled, acidified with TFA, diluted with water and prepped via rpHPLC to give the title compound. MS found for C18H22N8O as (M+H)+ 367.2.
후처리
- temperatureThe reaction mixture was cooled
출처 및 근거
- ORD 기록
- ord-a19ccca8d35144f0804de074e685fe15
- 출처 데이터셋
- uspto-grants-2014_11
- 특허 번호
- US08877760B2
연결된 노트
불러오는 중…